Drug intelligence / Profile preview

oxytocin + tibolone

Development stage
Unknown
Lead developer
Monash University’s Institute of Pharmaceutical Sciences (MIPS) and BioSyent Pharma Inc.
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Peptides, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Intravenous, Intramuscular, Intranasal, Oral
01

Overview

Oxytocin + tibolone is a hypothetical combination of two distinct drugs, oxytocin and tibolone, each with separate mechanisms and indications. Oxytocin is a peptide hormone produced in the hypothalamus, primarily used to induce or augment labor, control postpartum hemorrhage, and facilitate milk letdown by stimulating uterine smooth muscle contraction. Tibolone is a synthetic steroid hormone used as menopausal hormone therapy; it acts as an agonist at estrogen, progesterone, and androgen receptors through its active metabolites. Tibolone relieves vasomotor symptoms (such as hot flushes), improves vaginal atrophy and sexual function in postmenopausal women, and helps prevent osteoporosis by mimicking the effects of endogenous sex hormones[3][4][5][6][8]. There are no known marketed products or clinical evidence for a fixed-dose combination of oxytocin with tibolone.

02

Targets

PR (Progesterone receptor)ESR2 (ERβ)Oxytocin receptorAR (Adrenergic receptors)ESR1 (ERα)

Beyond the preview

Go deeper on oxytocin + tibolone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oxytocin + tibolone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call